BACKGROUND: A growing number of studies have shown that opioid craving (i.e., the perceived need or desire to consume opioids) is one of the strongest determinants of prescription opioid misuse in patients with chronic pain prescribed opioid therapy. To date, however, the factors that are associated with craving in patients with pain remain largely unexplored. Based on previous research, there is reason to believe that catastrophizing might be associated with heightened opioid craving. OBJECTIVES: To test the hypothesis that catastrophizing would be associated with heightened craving in patients with chronic pain prescribed long-term opioid therapy. DESIGN AND SUBJECTS, AND METHODS: In this cross-sectional study, 109 patients with chronic pain were asked to provide self-reports of catastrophizing and craving. Patients also provided self-reports of pain intensity and depressive symptoms. RESULTS: We found that higher levels of catastrophizing were associated with higher levels of craving. Importantly, results of a regression analysis revealed that the association between catastrophizing and craving remained significant even after controlling for a host of demographic (i.e., age, sex), psychological (i.e., depressive symptoms), medical (i.e., pain intensity, pain duration), and medication regimen (i.e., opioid doses) variables. CONCLUSIONS: Our preliminary findings provide valuable new insights into the determinants of craving in patients with pain. The finding that catastrophizing was associated with craving even after controlling for a host of demographic, psychological, medical, and medication regimen variables is particularly striking, and raises questions concerning the factors that underlie the association between catastrophizing and craving in patients prescribed opioid therapy. Wiley Periodicals, Inc.
BACKGROUND: A growing number of studies have shown that opioid craving (i.e., the perceived need or desire to consume opioids) is one of the strongest determinants of prescription opioid misuse in patients with chronic pain prescribed opioid therapy. To date, however, the factors that are associated with craving in patients with pain remain largely unexplored. Based on previous research, there is reason to believe that catastrophizing might be associated with heightened opioid craving. OBJECTIVES: To test the hypothesis that catastrophizing would be associated with heightened craving in patients with chronic pain prescribed long-term opioid therapy. DESIGN AND SUBJECTS, AND METHODS: In this cross-sectional study, 109 patients with chronic pain were asked to provide self-reports of catastrophizing and craving. Patients also provided self-reports of pain intensity and depressive symptoms. RESULTS: We found that higher levels of catastrophizing were associated with higher levels of craving. Importantly, results of a regression analysis revealed that the association between catastrophizing and craving remained significant even after controlling for a host of demographic (i.e., age, sex), psychological (i.e., depressive symptoms), medical (i.e., pain intensity, pain duration), and medication regimen (i.e., opioid doses) variables. CONCLUSIONS: Our preliminary findings provide valuable new insights into the determinants of craving in patients with pain. The finding that catastrophizing was associated with craving even after controlling for a host of demographic, psychological, medical, and medication regimen variables is particularly striking, and raises questions concerning the factors that underlie the association between catastrophizing and craving in patients prescribed opioid therapy. Wiley Periodicals, Inc.
Authors: Rajita Sinha; Makram Talih; Robert Malison; Ned Cooney; George M Anderson; Mary Jeanne Kreek Journal: Psychopharmacology (Berl) Date: 2003-07-04 Impact factor: 4.530
Authors: Francis J Keefe; John C Lefebvre; Jennifer R Egert; Glenn Affleck; Michael J Sullivan; David S Caldwell Journal: Pain Date: 2000-09 Impact factor: 6.961
Authors: Edward Michna; Edgar L Ross; Wilfred L Hynes; Srdjan S Nedeljkovic; Sharonah Soumekh; David Janfaza; Diane Palombi; Robert N Jamison Journal: J Pain Symptom Manage Date: 2004-09 Impact factor: 3.612
Authors: Yasamin Sharifzadeh; Ming-Chih Kao; John A Sturgeon; Thomas J Rico; Sean Mackey; Beth D Darnall Journal: Anesthesiology Date: 2017-07 Impact factor: 7.892
Authors: Andrew H Rogers; Brooke Y Kauffman; Jafar Bakhshaie; R Kathryn McHugh; Joseph W Ditre; Michael J Zvolensky Journal: Am J Drug Alcohol Abuse Date: 2019-03-21 Impact factor: 3.829
Authors: Patrick H Finan; C Patrick Carroll; Gyasi Moscou-Jackson; Marc O Martel; Claudia M Campbell; Alex Pressman; Joshua M Smyth; Jean-Michel Tremblay; Sophie M Lanzkron; Jennifer A Haythornthwaite Journal: J Pain Date: 2017-09-21 Impact factor: 5.820
Authors: Beth D Darnall; John A Sturgeon; Karon F Cook; Chloe J Taub; Anuradha Roy; John W Burns; Michael Sullivan; Sean C Mackey Journal: J Pain Date: 2017-05-19 Impact factor: 5.820
Authors: Marc O Martel; Patrick H Finan; R Kathryn McHugh; Mohammed Issa; Robert R Edwards; Robert N Jamison; Ajay D Wasan Journal: Drug Alcohol Depend Date: 2016-03-18 Impact factor: 4.492
Authors: Lindsay M Lueptow; Elizabeth C Shashkova; Margaret G Miller; Christopher J Evans; Catherine M Cahill Journal: Curr Anesthesiol Rep Date: 2020-09-29